Skip to main content
Protein Science : A Publication of the Protein Society logoLink to Protein Science : A Publication of the Protein Society
. 1994 Aug;3(8):1169–1177. doi: 10.1002/pro.5560030803

Primary structure and functional characterization of rat C5a: an anaphylatoxin with unusually high potency.

L Cui 1, D F Carney 1, T E Hugli 1
PMCID: PMC2142913  PMID: 7987212

Abstract

The anaphylatoxin C5a is a pro-inflammatory factor generated from C5 during complement activation. C5a derived from rat C5 exhibits significantly greater potency compared to C5a from other species. Rat C5a was 25-fold more potent than human C5a for eliciting spasmogenic contraction of guinea pig ileum. Proteolytic removal of the C-terminal arginine of C5a (C5adesArg) reduced spasmogenic potency of rat C5a by only 4-fold compared to a 3,000-fold reduction for human C5adesArg. In addition, rat C5adesArg was 50-fold more potent than human C5adesArg in a guinea pig vascular permeability (in vivo) assay and as a chemotactic factor for human neutrophils. C5a and C5adesArg were purified from zymosan-activated rat serum. Rat C5a, like human C5a, is glycosylated but contains 77 amino acid residues instead of the 74 residues of human C5a. Comparison of the primary structures of rat and human C5a indicated differences at 30 positions including an insert of 3 residues (LLH) in the rat molecule between residue positions 3 and 4 in human C5a. Insertion of residues LLH between Gln-3 and Lys-4 in a recombinant human C5a molecule using site-directed mutagenesis failed to enhance potency. Synthetic C-terminal analogues of rat C5a proved to be measurably more potent than the corresponding human C5a analogues (Ember JA et al., 1993, Protein Sci 2(Suppl 1):159 [Abstr]). We conclude that multiple sequence differences in the C-terminal effector portion and/or elsewhere in rat C5a, but not the LLH insert, account for the significant enhancement in potency of rat C5a over C5a from other species.

Full Text

The Full Text of this article is available as a PDF (3.6 MB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Boulay F., Mery L., Tardif M., Brouchon L., Vignais P. Expression cloning of a receptor for C5a anaphylatoxin on differentiated HL-60 cells. Biochemistry. 1991 Mar 26;30(12):2993–2999. doi: 10.1021/bi00226a002. [DOI] [PubMed] [Google Scholar]
  2. CRESTFIELD A. M., MOORE S., STEIN W. H. The preparation and enzymatic hydrolysis of reduced and S-carboxymethylated proteins. J Biol Chem. 1963 Feb;238:622–627. [PubMed] [Google Scholar]
  3. Carney D. F., Hugli T. E. Site-specific mutations in the N-terminal region of human C5a that affect interactions of C5a with the neutrophil C5a receptor. Protein Sci. 1993 Sep;2(9):1391–1399. doi: 10.1002/pro.5560020904. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Chenoweth D. E., Hugli T. E. Human C5a and C5a analogs as probes of the neutrophil C5a receptor. Mol Immunol. 1980 Feb;17(2):151–161. doi: 10.1016/0161-5890(80)90067-x. [DOI] [PubMed] [Google Scholar]
  5. Cochrane C. G., Müller-Eberhard H. J. The derivation of two distinct anaphylatoxin activities from the third and fifth components of human complement. J Exp Med. 1968 Feb 1;127(2):371–386. doi: 10.1084/jem.127.2.371. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Didsbury J. R., Uhing R. J., Tomhave E., Gerard C., Gerard N., Snyderman R. Receptor class desensitization of leukocyte chemoattractant receptors. Proc Natl Acad Sci U S A. 1991 Dec 15;88(24):11564–11568. doi: 10.1073/pnas.88.24.11564. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. FRIEDBERG K. D., ENGELHARDT G., MEINEKE F. UNTERSUCHUNGEN UEBER DIE ANAPHYLATOXIN-TACHYPHYLAXIE UND UEBER IHRE BEDEUTUNG FUER DEN ABLAUF ECHTER ANAPHYLAKTISCHER REAKTIONEN. Int Arch Allergy Appl Immunol. 1964;25:154–181. [PubMed] [Google Scholar]
  8. Fernandez H. N., Hugli T. E. Partial characterization of human C5a anaphylatoxin. I. Chemical description of the carbohydrate and polypeptide prtions of human C5a. J Immunol. 1976 Nov;117(5 Pt 1):1688–1694. [PubMed] [Google Scholar]
  9. Fernandez H. N., Hugli T. E. Primary structural analysis of the polypeptide portion of human C5a anaphylatoxin. Polypeptide sequence determination and assignment of the oligosaccharide attachment site in C5a. J Biol Chem. 1978 Oct 10;253(19):6955–6964. [PubMed] [Google Scholar]
  10. Friedman M., Krull L. H., Cavins J. F. The chromatographic determination of cystine and cysteine residues in proteins as s-beta-(4-pyridylethyl)cysteine. J Biol Chem. 1970 Aug 10;245(15):3868–3871. [PubMed] [Google Scholar]
  11. Gennaro R., Simonic T., Negri A., Mottola C., Secchi C., Ronchi S., Romeo D. C5a fragment of bovine complement. Purification, bioassays, amino-acid sequence and other structural studies. Eur J Biochem. 1986 Feb 17;155(1):77–86. doi: 10.1111/j.1432-1033.1986.tb09460.x. [DOI] [PubMed] [Google Scholar]
  12. Gerard C., Bao L., Orozco O., Pearson M., Kunz D., Gerard N. P. Structural diversity in the extracellular faces of peptidergic G-protein-coupled receptors. Molecular cloning of the mouse C5a anaphylatoxin receptor. J Immunol. 1992 Oct 15;149(8):2600–2606. [PubMed] [Google Scholar]
  13. Gerard C., Chenoweth D. E., Hugli T. E. Response of human neutrophils to C5a: a role for the oligosaccharide moiety of human C5ades Arg-74 but not of C5a in biologic activity. J Immunol. 1981 Nov;127(5):1978–1982. [PubMed] [Google Scholar]
  14. Gerard C., Hugli T. E. Amino acid sequence of the anaphylatoxin from the fifth component of porcine complement. J Biol Chem. 1980 May 25;255(10):4710–4715. [PubMed] [Google Scholar]
  15. Gerard C., Hugli T. E. Anaphylatoxin from the fifth component of porcine complement. Purification and partial chemical characterization. J Biol Chem. 1979 Jul 25;254(14):6346–6351. [PubMed] [Google Scholar]
  16. Gerard C., Hugli T. E. Identification of classical anaphylatoxin as the des-Arg form of the C5a molecule: evidence of a modulator role for the oligosaccharide unit in human des-Arg74-C5a. Proc Natl Acad Sci U S A. 1981 Mar;78(3):1833–1837. doi: 10.1073/pnas.78.3.1833. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Gerard C., Showell H. J., Hoeprich P. D., Jr, Hugli T. E., Stimler N. P. Evidence for a role of the amino-terminal region in the biological activity of the classical anaphylatoxin, porcine C5a des-Arg-74. J Biol Chem. 1985 Mar 10;260(5):2613–2616. [PubMed] [Google Scholar]
  18. Gerard N. P., Gerard C. The chemotactic receptor for human C5a anaphylatoxin. Nature. 1991 Feb 14;349(6310):614–617. doi: 10.1038/349614a0. [DOI] [PubMed] [Google Scholar]
  19. Hausman M. S., Snyderman R., Mergenhagen S. E. Humoral mediators of chemotaxis of mononuclear leukocytes. J Infect Dis. 1972 Jun;125(6):595–602. doi: 10.1093/infdis/125.6.595. [DOI] [PubMed] [Google Scholar]
  20. Hugli T. E. Biochemistry and biology of anaphylatoxins. Complement. 1986;3(3):111–127. doi: 10.1159/000467889. [DOI] [PubMed] [Google Scholar]
  21. Hugli T. E. Chemical aspects of the serum anaphylatoxins. Contemp Top Mol Immunol. 1978;7:181–214. doi: 10.1007/978-1-4757-0779-3_6. [DOI] [PubMed] [Google Scholar]
  22. Hugli T. E., Müller-Eberhard H. J. Anaphylatoxins: C3a and C5a. Adv Immunol. 1978;26:1–53. doi: 10.1016/s0065-2776(08)60228-x. [DOI] [PubMed] [Google Scholar]
  23. Johnson A. R., Hugli T. E., Müller-Eberhard H. J. Release of histamine from rat mast cells by the complement peptides C3a and C5a. Immunology. 1975 Jun;28(6):1067–1080. [PMC free article] [PubMed] [Google Scholar]
  24. Johnson A. R., Hugli T. E., Müller-Eberhard H. J. Release of histamine from rat mast cells by the complement peptides C3a and C5a. Immunology. 1975 Jun;28(6):1067–1080. [PMC free article] [PubMed] [Google Scholar]
  25. José P. J., Forrest M. J., Williams T. J. Human C5a des Arg increases vascular permeability. J Immunol. 1981 Dec;127(6):2376–2380. [PubMed] [Google Scholar]
  26. Keller H. U., Gerber H., Hess M. W., Cottier H. Studies on the regulation of the neutrophil chemotactic response using a rapid and reliable method for measuring random migration and chemotaxis of neutrophil granulocytes. Agents Actions. 1976 Feb;6(1-3):326–339. doi: 10.1007/BF01972250. [DOI] [PubMed] [Google Scholar]
  27. Koo C., Lefkowitz R. J., Snyderman R. The oligopeptide chemotactic factor receptor on human polymorphonuclear leukocyte membranes exists in two affinity states. Biochem Biophys Res Commun. 1982 May 31;106(2):442–449. doi: 10.1016/0006-291x(82)91130-5. [DOI] [PubMed] [Google Scholar]
  28. Perret J. J., Raspe E., Vassart G., Parmentier M. Cloning and functional expression of the canine anaphylatoxin C5a receptor. Evidence for high interspecies variability. Biochem J. 1992 Dec 15;288(Pt 3):911–917. doi: 10.1042/bj2880911. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Stimler N. P., Hugli T. E., Bloor C. M. Pulmonary injury induced by C3a and C5a anaphylatoxins. Am J Pathol. 1980 Aug;100(2):327–348. [PMC free article] [PubMed] [Google Scholar]
  30. Toth M. J., Huwyler L., Boyar W. C., Braunwalder A. F., Yarwood D., Hadala J., Haston W. O., Sills M. A., Seligmann B., Galakatos N. The pharmacophore of the human C5a anaphylatoxin. Protein Sci. 1994 Aug;3(8):1159–1168. doi: 10.1002/pro.5560030802. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Vallota E. H. Inhibition of C5 convertase by epsilon amino caproic acid (EACA): a limiting factor in the generation of C5a anaphylatoxin. Immunology. 1978 Mar;34(3):439–447. [PMC free article] [PubMed] [Google Scholar]
  32. Weber K., Osborn M. The reliability of molecular weight determinations by dodecyl sulfate-polyacrylamide gel electrophoresis. J Biol Chem. 1969 Aug 25;244(16):4406–4412. [PubMed] [Google Scholar]
  33. Wetsel R. A., Ogata R. T., Tack B. F. Primary structure of the fifth component of murine complement. Biochemistry. 1987 Feb 10;26(3):737–743. doi: 10.1021/bi00377a013. [DOI] [PubMed] [Google Scholar]
  34. Zuiderweg E. R., Nettesheim D. G., Mollison K. W., Carter G. W. Tertiary structure of human complement component C5a in solution from nuclear magnetic resonance data. Biochemistry. 1989 Jan 10;28(1):172–185. doi: 10.1021/bi00427a025. [DOI] [PubMed] [Google Scholar]

Articles from Protein Science : A Publication of the Protein Society are provided here courtesy of The Protein Society

RESOURCES